RAA
RDY icon

RWC Asset Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

RWC Asset Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,870
Closed -$600K – 21
2024
Q1 		$600K Hold
40,870
– – 0.05% 22
2023
Q4 		$569K Buy
+40,870
New +$546K 0.05% 19
2015
Q4 		– Sell
-100,000
Closed -$1.28M – 17
2015
Q3 		$1.28M Hold
100,000
– – 1.74% 13
2015
Q2 		$1.11M Buy
+100,000
New +$1.1M 1.45% 18

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RWC Asset Advisors's RDY Position: Q2 2024 in Review

RWC Asset Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 40,870 shares — an estimated $600K sold.

RWC Asset Advisors first reported a position in RDY in Q2 2015 and held it in 4 quarters. The position peaked at $1.28M in Q3 2015. 221 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • RWC Asset Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • RWC Asset Advisors sold 40,870 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $600K.
  • RWC Asset Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 4 quarters.
  • RWC Asset Advisors's Dr. Reddy's Laboratories position peaked at $1.28M in Q3 2015.
  • 221 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on RWC Asset Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.